A cross-sectional study of 651 middle-aged breast cancer patients in China found that 21.2% experienced clinically relevant fatigue during chemotherapy. The main predictors were depression, pain interference, lack of medical insurance, treatment duration of 3–12 months, and later chemotherapy cycles, underscoring the need for early psychosocial and pain management support.